
Pictured (l-r) is Professor David Henshall (RCSI Professor of Molecular Physiology and Neuroscience) speaking at the first innovation showcase co-hosted by RCSI and Trinity College Dublin, held on Tuesday 17th May. The showcase promoted examples of the next wave of biomedical and life sciences research being undertaken within both institutions and profile examples of successful spinout companies, commercialising academic research and ongoing industry engagements. It also highlighted how this knowledge transfer consortium will enhance research commercialisation and provide opportunities for industry to engage across both institutions. During his presentation, Professor Henshall explored the potential to manage diseases such as epilepsy by delivering novel treatments that are informed by genome interrogation as well as medical devices that monitor response to treatment in real-time.